BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 33493916)

  • 21. A Comparative Analysis of Radical Scavenging, Antifungal and Enzyme Inhibition Activity of 3'-8″-Biflavones and Their Monomeric Subunits.
    Jurčević Šangut I; Šarkanj B; Karalija E; Šamec D
    Antioxidants (Basel); 2023 Oct; 12(10):. PubMed ID: 37891933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU.
    Sharifipour E; Shams S; Esmkhani M; Khodadadi J; Fotouhi-Ardakani R; Koohpaei A; Doosti Z; Ej Golzari S
    BMC Infect Dis; 2020 Sep; 20(1):646. PubMed ID: 32873235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV-2 detection in setting of viral swabs scarcity: Are MRSA swabs and viral swabs equivalent?
    Federman DG; Gupta S; Stack G; Campbell SM; Peaper DR; Dembry LM; Fisher A; Tarabar AF; Kozal M; Ruser CB
    PLoS One; 2020; 15(8):e0237127. PubMed ID: 32756602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy.
    Goyal B; Goyal D
    ACS Comb Sci; 2020 Jun; 22(6):297-305. PubMed ID: 32402186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multipurpose Drugs Active Against Both
    Endo T; Takemae H; Sharma I; Furuya T
    Front Cell Infect Microbiol; 2021; 11():797509. PubMed ID: 35004357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking and Virtual Screening.
    Chtita S; Belhassan A; Aouidate A; Belaidi S; Bouachrine M; Lakhlifi T
    Comb Chem High Throughput Screen; 2021; 24(3):441-454. PubMed ID: 32748740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evolving geographic diversity in SARS-CoV2 and in silico analysis of replicating enzyme 3CL
    Chitranshi N; Gupta VK; Rajput R; Godinez A; Pushpitha K; Shen T; Mirzaei M; You Y; Basavarajappa D; Gupta V; Graham SL
    J Transl Med; 2020 Jul; 18(1):278. PubMed ID: 32646487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.
    Ye C; Chiem K; Park JG; Oladunni F; Platt RN; Anderson T; Almazan F; de la Torre JC; Martinez-Sobrido L
    mBio; 2020 Sep; 11(5):. PubMed ID: 32978313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biflavonoids: Important Contributions to the Health Benefits of Ginkgo (
    Šamec D; Karalija E; Dahija S; Hassan STS
    Plants (Basel); 2022 May; 11(10):. PubMed ID: 35631806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complete NMR assignments of the antibacterial biflavonoid GB1 from Garcinia kola.
    Han QB; Lee SF; Qiao CF; He ZD; Song JZ; Sun HD; Xu HX
    Chem Pharm Bull (Tokyo); 2005 Aug; 53(8):1034-6. PubMed ID: 16079543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
    Froggatt HM; Heaton BE; Heaton NS
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug Discovery Strategies for SARS-CoV-2.
    Shyr ZA; Gorshkov K; Chen CZ; Zheng W
    J Pharmacol Exp Ther; 2020 Oct; 375(1):127-138. PubMed ID: 32723801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of phospholipase A2 inhibitory biflavonoids.
    Chen J; Chang HW; Kim HP; Park H
    Bioorg Med Chem Lett; 2006 May; 16(9):2373-5. PubMed ID: 16504502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the antihepatotoxic activity of the biflavonoids of Garcinia kola seed.
    Iwu MM; Igboko OA; Onwuchekwa UA; Okunji CO
    J Ethnopharmacol; 1987 Nov; 21(2):127-38. PubMed ID: 3437766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hinokiflavone and Related C-O-C-Type Biflavonoids as Anti-cancer Compounds: Properties and Mechanism of Action.
    Goossens JF; Goossens L; Bailly C
    Nat Prod Bioprospect; 2021 Aug; 11(4):365-377. PubMed ID: 33534099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemical composition and anti-Mayaro virus activity of
    Salles TS; Meneses MDF; Yamamoto KA; Sá-Guimarães TE; Caldas LA; Silva JHS; da Silva Ferreira P; Amaral ACF; Ventura JA; Azevedo RC; Kuster RM; Soares MR; Ferreira DF
    Virusdisease; 2021 Sep; 32(3):526-534. PubMed ID: 34631977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ginkgetin: A natural biflavone with versatile pharmacological activities.
    Adnan M; Rasul A; Hussain G; Shah MA; Zahoor MK; Anwar H; Sarfraz I; Riaz A; Manzoor M; Adem Ş; Selamoglu Z
    Food Chem Toxicol; 2020 Nov; 145():111642. PubMed ID: 32783998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural products' role against COVID-19.
    Antonio ADS; Wiedemann LSM; Veiga-Junior VF
    RSC Adv; 2020 Jun; 10(39):23379-23393. PubMed ID: 35693131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of flavonoids on membrane adaptation of food-associated bacteria.
    Linden M; Flegler A; Feuereisen MM; Weber F; Lipski A; Schieber A
    Biochim Biophys Acta Biomembr; 2023 Apr; 1865(4):184137. PubMed ID: 36746312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.